APA (7th ed.) Citation

Winkler, E. S., Gilchuk, P., Yu, J., Bailey, A. L., Chen, R. E., Chong, Z., . . . Diamond, M. S. (2021). Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell, 184(7), 1804-1820.e16. https://doi.org/10.1016/j.cell.2021.02.026

Chicago Style (17th ed.) Citation

Winkler, Emma S., et al. "Human Neutralizing Antibodies Against SARS-CoV-2 Require Intact Fc Effector Functions for Optimal Therapeutic Protection." Cell 184, no. 7 (2021): 1804-1820.e16. https://doi.org/10.1016/j.cell.2021.02.026.

MLA (9th ed.) Citation

Winkler, Emma S., et al. "Human Neutralizing Antibodies Against SARS-CoV-2 Require Intact Fc Effector Functions for Optimal Therapeutic Protection." Cell, vol. 184, no. 7, 2021, pp. 1804-1820.e16, https://doi.org/10.1016/j.cell.2021.02.026.